Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring study
- 31 August 1992
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 124 (2), 381-386
- https://doi.org/10.1016/0002-8703(92)90601-q
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.Circulation, 1991
- Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.Circulation, 1989
- Random and nonrandom behavior of symptomatic paroxysmal atrial fibrillationThe American Journal of Cardiology, 1989
- Clinical behavior of paroxysmal atrial tachycardiaThe American Journal of Cardiology, 1988
- The spontaneous occurrence of paroxysmal supraventricular tachycardia.Circulation, 1984
- Arrhythmias Detected by Ambulatory MonitoringChest, 1980
- Occurrence of Frequent Complex Arrhythmias Detected by Ambulatory MonitoringChest, 1979
- The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged menThe American Journal of Cardiology, 1969